{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:08:16Z","timestamp":1784365696869,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003350","name":"Mapfre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015080","name":"Rafael del Pino Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015080","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jcyt.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T11:32:14Z","timestamp":1478086334000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury"],"prefix":"10.1016","volume":"19","author":[{"given":"Jes\u00fas","family":"Vaquero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Zurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mucientes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edelio","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Donis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2016.10.001_bib0010","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jcyt.2016.05.003","article-title":"An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I\/II clinical trial","volume":"18","author":"Vaquero","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pneurobio.2010.12.002","article-title":"Functional recovery after severe central nervous system trauma: current perspectives for cell therapy with bone marrow stromal cells","volume":"93","author":"Vaquero","year":"2011","journal-title":"Progr Neurobiol"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/02699050903133970","article-title":"Delayed intralesional transplantation of bone marrow stromal cells increases endogenous neurogenesis and promotes functional recovery after severe traumatic brain injury","volume":"23","author":"Bonilla","year":"2009","journal-title":"Brain Injury"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13287-015-0034-0","article-title":"Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury","volume":"6","author":"Peng","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.6002\/ect.2012.0053","article-title":"Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture","volume":"11","author":"Tian","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0035","first-page":"118","article-title":"Disability rating scale for severe head trauma: coma to community","volume":"63","author":"Rappaport","year":"1982","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3413\/Nukmed-0543-12-11","article-title":"Bone marrow mesenchymal stem cell transplantation in acute brain trauma. Improvement ofbrain glucose metabolism in a rat model","volume":"52","author":"Park","year":"2013","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0045","doi-asserted-by":"crossref","first-page":"905874","DOI":"10.1155\/2015\/905874","article-title":"A clinical study of autologous bone marrow mononuclear cells for cerebral palsy patients: a new frontier","volume":"2015","author":"Sharma","year":"2015","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0050","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3174\/ajnr.A3695","article-title":"PET approaches for diagnosis of dementia","volume":"35","author":"Ishii","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2011.06015.x","article-title":"PET\/CT in diagnosis of dementia","volume":"1228","author":"Bert","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0060","first-page":"233","article-title":"18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients","volume":"46","author":"Jeonh","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0065","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","article-title":"A multi-center randomized proof-of-concept clinical trial applying [18F] FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease","volume":"22","author":"Tzimopoulou","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0070","first-page":"11","article-title":"Evaluation of therapeutic response to donepezil by positr\u00f3n emission tomography","volume":"57","author":"Shimada","year":"2011","journal-title":"Osaka City Med J"},{"key":"10.1016\/j.jcyt.2016.10.001_bib0075","first-page":"63","article-title":"Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease","volume":"14","author":"Mega","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916305461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916305461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:23:41Z","timestamp":1761431021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324916305461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1465324916305461"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.10.001","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive increase in brain glucose metabolism after intrathecal administration of autologous mesenchymal stromal cells in patients with diffuse axonal injury","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}